Heart Diseases: Clinical Trials

28,124 trials for Heart Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14355 completed, 5306 unknown, 3269 recruiting, 1642 terminated. 10345 Not applicable, 2570 Phase 4, 2063 Phase 2, 2007 Phase 3, 873 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10345Completed 4989, Unknown 1816, Recruiting 1312, Not yet recruiting 646, Terminated 622, Active not recruiting 493, Withdrawn 331, Enrolling by invitation 105, Suspended 31
Phase 42570Completed 1374, Unknown 566, Terminated 220, Recruiting 182, Withdrawn 82, Not yet recruiting 81, Active not recruiting 50, Enrolling by invitation 8, Suspended 7
Phase 22063Completed 1178, Unknown 296, Terminated 222, Recruiting 162, Withdrawn 89, Not yet recruiting 52, Active not recruiting 43, Suspended 12, Enrolling by invitation 9
Phase 32007Completed 1189, Unknown 282, Terminated 204, Recruiting 166, Not yet recruiting 56, Withdrawn 49, Active not recruiting 45, Enrolling by invitation 9, Suspended 7
Phase 1873Completed 532, Unknown 108, Terminated 77, Recruiting 64, Withdrawn 48, Not yet recruiting 21, Active not recruiting 13, Suspended 9, Enrolling by invitation 1
Early Phase 1131Completed 63, Unknown 21, Recruiting 14, Withdrawn 11, Not yet recruiting 9, Terminated 9, Active not recruiting 2, Enrolling by invitation 2

Follow Heart Diseases: new trials by email Literature Review of Heart Diseases trials Research Report on Heart Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
Ferrous sulfate 325mg - Right Ventricular Dysfunction, Hypoxia
Early Phase 1Not yet recruitingUniversity of Colorado, Denver52028-03-012026-04-29
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
Heart Failure, Preserved Ejection Fraction
Not yet recruitingBoehringer Ingelheim30002028-01-312026-09-16
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
Video-assisted thoracoscopic closure of the left atrial appendage using a closure device and discontinuation of treatment if the patient is treated with OAC - ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Oral Anticoagulation
Not applicableNot yet recruitingRegion Skane9362028-01-012026-07-15
Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest
Out of Hospital Cardiac Arrest, Computed Tomography
Not yet recruitingNational Taiwan University Hospital50002027-12-312025-11-19
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation
Abelacimab - Atrial Fibrillation (AF)
Phase 3Not yet recruitingNovartis Pharmaceuticals25002027-12-302026-07-31
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease
Phase 2Not yet recruitingVenturis Therapeutics, Inc.1502027-09-012026-08-19
Conscious Sedation Study
CLAAS® System - Atrial Fibrillation
Not applicableNot yet recruitingConformal Medical, Inc3002027-08-012026-03-20
Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT
Trametinib - HCM, Noonan Syndrome and Other Rasopathy
Phase 3Not yet recruitingCarelon Research252027-08-012026-09-14
Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)
Right Heart Catheterization - Tricuspid Regurgitation (TR)
Not yet recruitingFeldman Cardiology, PLLC82027-07-102026-03-30
Aficamten and Patient-Reported Outcomes in Real-World nHCM
receiving aficamten - Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002027-06-012026-09-29
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)
[11C] acetate - Mitral Valve Regurgitation
Early Phase 1WithdrawnUniversity of Alabama at Birmingham2027-06-012025-01-24
Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease
Polygenic risk score - Coronary Heart Disease
Not yet recruitingMedical College of Wisconsin2002027-06-012026-05-04
Registry on Luma Vision's VERAFEYE System (ENLIgHT)
VERAFEYE System - Atrial Fibrillation, Left Atrial Appendage Closure
Not yet recruitingLUMA Vision Ltd.502027-05-152026-09-15
The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That Are Shockable in Cardiac Arrest Trial
defibrillator electrode pads - Cardiac Arrest (CA)
Not applicableNot yet recruitingOregon Health and Science University15002027-04-012026-09-14
Heart tEam Decision-making Assisted by Revaz AI Trial
Revaz AI - Coronary Artery Disease
Not applicableNot yet recruitingUniversity of Calgary7122027-04-012026-09-24
TORCH-LATAM-003: Regional Advanced-Therapy Pathways for Congenital Heart Disease
TORCH Congenital Advanced Therapies Pathway (TORCH-CATP) - Congenital Heart Disease, Advanced Heart Failure
Not applicableNot yet recruitingCardioVision International Tech, S.A.S. de C.V.3602027-03-302026-10-13
The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
Zio XT® Patch - Atrial Fibrillation
Not applicableNot yet recruitingVA Office of Research and Development240602027-03-082026-06-30
OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation
Oral anticoagulation, Single antiplatelet therapy - Atrial Fibrillation (AF), Coronary Artery Disease
Phase 4Not yet recruitingEwha Womans University Mokdong Hospital22027-03-012026-03-27
WSO BEAT STROKE Initiative
Educational and implementation Neurocardiology tool, No educational or implementation tool will be provided - Stroke, PFO - Patent Foramen Ovale
Not applicableNot yet recruitingLuciano A. Sposato24002027-03-012026-09-18
Lattice vs Pentaspline Comparative Evaluation in Persistent AF
Pulmonary vein isolation - Persistent Atrial Fibrillation
Not applicableNot yet recruitingMitera Hospital2502027-03-012026-09-15

Showing 20 of 28124. Sign in to see all of them.

Narrower conditions

Heart Failure (5584)  ·  Coronary Artery Disease (4729)  ·  Atrial Fibrillation (3821)  ·  Myocardial Infarction (1960)  ·  Cardiovascular Diseases (1914)  ·  Coronary Disease (1498)  ·  Acute Coronary Syndrome (1460)  ·  Myocardial Ischemia (1094)  ·  Arrhythmias, Cardiac (1048)  ·  Heart Defects, Congenital (988)  ·  Aortic Valve Stenosis (986)  ·  Heart Arrest (898)  ·  ST Elevation Myocardial Infarction (826)  ·  Stroke (802)

Broader conditions

Cardiovascular Diseases (26210)  ·  Pathological Conditions, Signs and Symptoms (12530)  ·  Vascular Diseases (11978)  ·  Pathologic Processes (10687)  ·  Myocardial Ischemia (9318)  ·  Arterial Occlusive Diseases (4996)  ·  Arteriosclerosis (4960)  ·  Arrhythmias, Cardiac (4709)  ·  Coronary Disease (4661)  ·  Necrosis (3013)  ·  Infarction (2986)  ·  Ischemia (2974)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2623)  ·  Signs and Symptoms (2508)

Interventions

Clopidogrel (380)  ·  Aspirin (290)  ·  Percutaneous Coronary Intervention (273)  ·  Ticagrelor (250)  ·  Exercise (232)  ·  Catheter Ablation (194)  ·  Standard of Care (191)  ·  Echocardiography (187)  ·  Blood Specimen Collection (174)  ·  Atorvastatin (171)  ·  Rivaroxaban (170)  ·  Sodium Chloride (169)  ·  Transcatheter Aortic Valve Replacement (162)  ·  Warfarin (140)  ·  Saline Solution (139)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (557)  ·  Abbott Medical Devices (378)  ·  Boston Scientific Corporation (233)  ·  Assiut University (229)  ·  Mayo Clinic (216)  ·  Medtronic Cardiac Rhythm and Heart Failure (208)  ·  Assistance Publique - Hôpitaux de Paris (207)  ·  Yonsei University (186)  ·  China National Center for Cardiovascular Diseases (157)  ·  AstraZeneca (141)  ·  Seoul National University Hospital (140)  ·  Duke University (134)  ·  National Taiwan University Hospital (130)  ·  Ottawa Heart Institute Research Corporation (123)  ·  Beijing Anzhen Hospital (118)

Countries

United States (7242)  ·  Germany (2349)  ·  China (2346)  ·  France (2140)  ·  Italy (1913)  ·  Canada (1894)  ·  United Kingdom (1857)  ·  Netherlands (1365)  ·  Spain (1356)  ·  South Korea (1173)  ·  Denmark (1049)  ·  Belgium (972)  ·  Poland (900)  ·  Switzerland (810)  ·  Sweden (726)

Top investigators

Vivek Reddy, MD (34)  ·  Andrea Natale, MD (32)  ·  Seung-Jung Park, MD, PhD (31)  ·  Adnan Kastrati, MD (30)  ·  Bon-Kwon Koo, MD, PhD (26)  ·  Dhanunjaya Lakkireddy, MD (23)

Results publications

PMID 35224730, PMID 32860505, PMID 19717846, PMID 20961243, PMID 40875095, PMID 31081589, PMID 34447992, PMID 36700520, PMID 41114449, PMID 25940520, PMID 28886621, PMID 31535829, PMID 33962483, PMID 34932836, PMID 17982182, PMID 21670242, PMID 23636237, PMID 24746650, PMID 26354543, PMID 31698933, PMID 34022170, PMID 34693515, PMID 34741536, PMID 36398903, PMID 37131096, PMID 37366061, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 19228612, PMID 19463432, PMID 19737719, PMID 19923168, PMID 20142198, PMID 20236866, PMID 21639811, PMID 22236222, PMID 23468513, PMID 23523454, PMID 25173339, PMID 26320110, PMID 26347918, PMID 27042964, PMID 27206819, PMID 29098321, PMID 29555836, PMID 30165437, PMID 31561250, PMID 31690104

NIH funding

2023 (69), 2019 (62), 2025 (57), 2016 (56), 2018 (54), 2009 (36), 2014 (36), 2017 (36), 2015 (31), 2008 (19), 2005 (13), U01HL088942 (13), 2004 (9), U01HL068270 (9), P30AG064198 (8)